So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2020 Financial Results
So-Young International Inc. (Nasdaq: SY) reported its Q4 and full-year 2020 financial results, revealing Q4 revenues of RMB424.6 million (US$65.1 million), marking an 18.6% increase year-over-year. However, net income fell to RMB37.7 million (US$5.8 million) from RMB69.9 million in 2019. For the entire year, total revenues reached RMB1,295.0 million (US$198.5 million), up 12.4% from 2019, yet net income drastically decreased to RMB4.9 million (US$0.7 million). The company anticipates Q1 2021 revenues between RMB320 million and RMB330 million, reflecting a projected 75.3%-80.8% growth.
- Q4 2020 total revenues increased by 18.6% year-over-year.
- Average mobile MAUs grew 142.3% to 8.9 million.
- Number of paying medical service providers increased 40.5% to 4,746.
- Gross margin improved to 85.0% in Q4 2020 from 83.7% in Q4 2019.
- Net income for Q4 2020 decreased to RMB37.7 million from RMB69.9 million in Q4 2019.
- Non-GAAP net income dropped to RMB62.2 million from RMB86.4 million in the same period last year.
- Total operating expenses rose 48.6% to RMB331.2 million in Q4 2020.
BEIJING, China, March 22, 2021 (GLOBE NEWSWIRE) -- So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.
Fourth Quarter 2020 Financial Highlights
- Total revenues were RMB424.6 million (US
$65.1 million 1), an increase of18.6% from RMB358.2 million in the same period of 2019, in line with our previous guidance. - Net income was RMB37.7 million (US
$5.8 million ), compared with a net income RMB69.9 million in the same period of 2019. - Non-GAAP net income2 was RMB62.2 million (US
$9.5 million ), compared with a non-GAAP net income of RMB86.4 million in the same period of 2019.
Fourth Quarter 2020 Operational Highlights
- Average mobile MAUs were 8.9 million, an increase of
142.3% from 3.7 million in the fourth quarter of 2019. - Total number of users purchasing reservation service were 194,769 and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young’s platform was RMB969.3 million.
- Number of paying medical service providers on So-Young’s platform were 4,746, an increase of
40.5% from 3,378 in the fourth quarter of 2019.
Fiscal Year 2020 Financial Highlights
- Total revenues were RMB1,295.0 million (US
$198.5 million ) in the full year 2020, an increase of12.4% from RMB1,151.6 million in the prior year. - Net income was RMB4.9 million (US
$0.7 million ) in the full year 2020, compared with a net income RMB176.7 million in the prior year. - Non-GAAP net income was RMB97.0 million (US
$14.9 million ) in the full year 2020, compared with a non-GAAP net income of RMB280.9 million in the prior year.
Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, “We ended a very challenging year of 2020 with a solid quarter of growth in-line with our guidance. During the past year, we successfully carried out key initiatives that continued to fully leverage our high-quality content, robust technology, and the years of trust we have built with users and medical service providers in China. Strong user growth momentum continued in the fourth quarter due to the expansion of our content library and the launch of innovative services such as “VR Store” and “Live Diagnosis”. In the fourth quarter of 2020, the average mobile MAUs reached 8.9 million, an increase of
Mr. Jin continued, “Looking at 2021, we are continuously enhancing our community-based content offerings to address different needs from the enlarged pool of users, especially those who are core consumers for medical aesthetic services. On the business front, we will continue to solidify our advantages in plastic surgery, which has been traditionally our strength while we will also capture the tremendous opportunities in non-surgical categories which will continue their strong growth in the coming year. Lastly, we will continue to upgrade our products and services and improve user experience. Looking forward into the future, we will fully leverage our competitive edges in content offering, technology and user base, be user-centric, deeply explore the medical aesthetic industrial chain, and become the most trusted platform in the broader consumption healthcare service industry starting from aesthetics.”
Mr. Min Yu, Chief Financial Officer of So-Young, also commented, “Total revenues for the fourth quarter were RMB424.6 million, up
Fourth Quarter 2020 Financial Results
Revenues
Total revenues were RMB424.6 million (US
- Information services revenues were RMB335.9 million (US
$51.5 million ), an increase of27.0% from RMB264.5 million in the same period of 2019. The increase was mainly due to an increase in average revenue per paying medical service provider. Total number of paying medical service providers subscribing to information services on So-Young’s platform was 2,239 during the quarter. - Reservation services revenues were RMB88.7 million (US
$13.6 million ), a decrease of5.3% from RMB93.7 million in the same period of 2019. The decrease was primarily because surgical transactions were still gradually recovering to the peak season of last year before the Covid-19 pandemic.
Cost of Revenues
Cost of revenues were RMB63.6 million (US
Operating Expenses
Total operating expenses were RMB331.2 million (US
- Sales and marketing expenses were RMB210.4 million (US
$32.2 million ), an increase of59.2% from RMB132.2 million in the fourth quarter of 2019. The increase was primarily due to an increase in expenses associated with marketing activities and payroll costs. Sales and marketing expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB2.2 million (US$0.3 million ), compared with RMB2.4 million in the corresponding period of 2019. - General and administrative expenses were RMB49.9 million (US
$7.6 million ), an increase of38.4% from RMB36.0 million in the fourth quarter of 2019. The increase was primarily due to an increase in payroll costs associated with the expansion of administrative employees. General and administrative expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB11.3 million (US$1.7 million ), compared with RMB5.1 million in the corresponding period of 2019. - Research and development expenses were RMB70.9 million (US
$10.9 million ), an increase of29.6% from RMB54.7 million in the fourth quarter of 2019. The increase was primarily attributable to an increase in payroll costs. Research and development expenses for the fourth quarter of 2020 included share-based compensation expenses of RMB5.9 million (US$0.9 million ) , compared with RMB4.9 million in the corresponding period of 2019.
Income Tax Expenses
Income tax expenses were RMB13.0 million (US
Net income
Net income was RMB37.7 million (US
Non-GAAP net income
Non-GAAP net income, which excludes the impact of share-based compensation expenses, was RMB62.2 million (US
Basic and Diluted Earnings per ADS
Basic and diluted earnings per ADS attributable to ordinary shareholders were RMB0.36 (US
Fiscal Year 2020 Financial Results
Revenues
Total revenues were RMB1,295.0 million (US
- Information services revenues were RMB962.1 million (US
$147.4 million ), an increase of15.4% from RMB833.4 million in fiscal year 2019. The increase was primarily attributable to an increase in average revenue per medical service provider as they increasingly allocate a larger proportion of their marketing budgets to So-Young’s platform.
- Reservation services revenues were RMB332.9 million (US
$51.0 million ), an increase of4.6% from RMB318.2 million in fiscal year 2019. The increase was primarily due to an increase in the number of purchasing users.
Cost of Revenues
Cost of revenues were RMB212.2 million (US
Operating Expenses
Total operating expenses were RMB1,139.5 million (US
- Sales and marketing expenses were RMB726.3 million (US
$111.3 million ), an increase of54.5% from RMB470.0 million in fiscal year 2019. The increase was primarily due to an increase in expenses associated with branding and marketing activities. Sales and marketing expenses for 2020 included share-based compensation expenses of RMB6.7 million (US$1.0 million ), compared to RMB8.5 million in 2019. - General and administrative expenses were RMB184.0 million (US
$28.2 million ), an increase of14.6% from RMB160.5 million in fiscal year 2019. This was primarily due to an increase in personnel related expenses. General and administrative expenses for 2020 included share-based compensation expenses of RMB46.0 million (US$7.1 million ), compared to RMB61.6 million in 2019. - Research and development expenses were RMB229.2 million (US
$35.1 million ), an increase of29.3% from RMB177.3 million in fiscal year 2019. The increase was primarily attributable to an increase in personnel related expenses. Research and development expenses for 2020 included share-based compensation expenses of RMB21.1 million (US$3.2 million ), compared to RMB21.4 million in 2019.
Income Tax (Expenses)/Benefit
Income tax benefit was RMB4.8 million (US
Net Income
Net income was RMB4.9 million (US
Non-GAAP net income
Non-GAAP net income, which excludes the impact of share-based compensation expenses, was RMB97.0 million (US
Basic and Diluted Earnings per ADS
Basic and diluted earnings per ADS attributable to ordinary shareholders were RMB0.05 (US
Cash and Cash Equivalents, Restricted Cash and Term Deposits, Term Deposits and Short-Term Investments
As of December 31, 2020, cash and cash equivalents, restricted cash and term deposits, term deposits and short-term investments were RMB2,676.0 million (US
Business Outlook
For the first quarter of 2021, So-Young expects total revenues to be between RMB320 million (US
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States, or GAAP, this press release presents non-GAAP income from operations and non-GAAP net income by excluding share-based compensation expenses from income from operations and net income, respectively. The Company believes these non-GAAP financial measures are important to help investors understand the Company’s operating and financial performance, compare business trends among different reporting periods on a consistent basis and assess the Company’s core operating results, as they exclude certain expenses that are not expected to result in cash payments. The use of the above non-GAAP financial measures has certain limitations. Share-based compensation expenses have been and will continue to be incurred in the future and are not reflected in the presentation of the non-GAAP financial measures, but should be considered in the overall evaluation of the Company’s results. The Company compensates for these limitations by providing the relevant disclosure of its share-based compensation expenses in the reconciliations to the most directly comparable GAAP financial measures, which should be considered when evaluating the Company’s performance. These non-GAAP financial measures should be considered in addition to financial measures prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measure is set forth at the end of this release.
Conference Call Information
So-Young’s management will hold an earnings conference call on Monday, March 22, 2021, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Participants can register for the conference call by navigating to http://apac.directeventreg.com/registration/event/2133378.
Once preregistration has been completed, participants will receive dial-in numbers, an event passcode, and a unique registrant ID.
To join the conference, please dial the number you receive, enter the event passcode followed by your unique registrant ID, and you will be joined to the conference instantly.
A telephone replay will be available two hours after the conclusion of the conference call through 8:59 AM U.S. Eastern Time, March 30, 2021. The dial-in details are:
| International: | +61-2-8199-0299 |
| US: | +1-646-254-3697 |
| Passcode: | 2133378 |
Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.
About So-Young International Inc.
So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”) is the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry. The Company presents users with reliable information through offering high quality and trustworthy content together with a multitude of social functions on its platform, as well as by curating medical aesthetic service providers that are carefully selected and vetted. Leveraging So-Young’s strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well-positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Young’s strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about So-Young’s beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Young’s strategies; So-Young’s future business development, financial condition and results of operations; So-Young’s ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Young’s revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; the impact of the COVID-19 pandemic to So-Young’s business operations and the economy in China and elsewhere generally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.
For more information, please contact:
So-Young
Investor Relations
Ms. Vivian XU
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-10-5900-1548
E-mail: Eyuan@christensenir.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com
SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except for share and per share data)
| As of | |||||
| December 31, 2019 | December 31, 2020 | December 31, 2020 | |||
| RMB | RMB | US$ | |||
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | 884,676 | 1,127,055 | 172,729 | ||
| Restricted cash and term deposits | 16,509 | 21,865 | 3,352 | ||
| Trade receivables | 26,110 | 52,871 | 8,103 | ||
| Receivables from online payment platforms | 13,429 | 16,182 | 2,480 | ||
| Amounts due from related parties | 5,815 | 7,764 | 1,190 | ||
| Term deposits and short-term investments | 1,942,860 | 1,527,088 | 234,036 | ||
| Prepayment and other current assets | 67,628 | 43,190 | 6,619 | ||
| Total current assets | 2,957,027 | 2,796,015 | 428,509 | ||
| Non-current assets: | |||||
| Long-term investments | 45,980 | 166,100 | 25,456 | ||
| Intangible assets | 726 | 60,029 | 9,200 | ||
| Goodwill | - | 48,500 | 7,433 | ||
| Property and equipment, net | 32,341 | 29,830 | 4,572 | ||
| Deferred tax assets | 35,208 | 55,520 | 8,509 | ||
| Operating lease right-of-use assets | 144,488 | 120,140 | 18,412 | ||
| Other non-current assets | 14,184 | 15,878 | 2,433 | ||
| Total non-current assets | 272,927 | 495,997 | 76,015 | ||
| Total assets | 3,229,954 | 3,292,012 | 504,524 | ||
| Liabilities | |||||
| Current liabilities: | |||||
| Taxes payable | 65,605 | 60,070 | 9,207 | ||
| Contract liabilities | 93,725 | 135,385 | 20,749 | ||
| Salary and welfare payables | 100,676 | 95,758 | 14,676 | ||
| Amounts due to related parties | 2,620 | 2,404 | 368 | ||
| Accrued expenses and other current liabilities | 166,088 | 237,785 | 36,442 | ||
| Operating lease liabilities-current | 37,799 | 39,468 | 6,049 | ||
| Total current liabilities | 466,513 | 570,870 | 87,491 | ||
| Non-current liabilities: | |||||
| Operating lease liabilities-non current | 120,803 | 93,044 | 14,260 | ||
| Deferred tax liabilities | - | 8,522 | 1,306 | ||
| Total non-current liabilities | 120,803 | 101,566 | 15,566 | ||
| Total liabilities | 587,316 | 672,436 | 103,057 | ||
| Mezzanine equity | |||||
| Redeemable non-controlling interests | - | 23,205 | 3,556 | ||
| Total mezzanine equity | - | 23,205 | 3,556 | ||
SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)
(All amounts in thousands, except for share and per share data, unless otherwise noted)
| Shareholders’ equity: | |||||||||
| Class A Ordinary shares (US | 221 | 224 | 34 | ||||||
| Class B Ordinary shares (US | 37 | 37 | 6 | ||||||
| Additional paid-in capital | 2,799,336 | 2,892,268 | 443,259 | ||||||
| Statutory reserves | 10,562 | 10,562 | 1,619 | ||||||
| Accumulated deficit | (259,251 | ) | (254,228 | ) | (38,962 | ) | |||
| Accumulated other comprehensive income/(loss) | 91,733 | (52,492 | ) | (8,045 | ) | ||||
| Total shareholders’ equity | 2,642,638 | 2,596,371 | 397,911 | ||||||
| Total liabilities, mezzanine equity and shareholders’ equity | 3,229,954 | 3,292,012 | 504,524 | ||||||
SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Amounts in thousands, except for share and per share data)
| For the Three Months Ended | For the Fiscal Year Ended | ||||||||||||||||||
| December 31, 2019 | December 31, 2020 | December 31, 2020 | December 31, 2019 | December 31, 2020 | December 31, 2020 | ||||||||||||||
| RMB | RMB | US$ | RMB | RMB | US$ | ||||||||||||||
| Revenues | |||||||||||||||||||
| Information services | 264,517 | 335,911 | 51,481 | 833,422 | 962,089 | 147,447 | |||||||||||||
| Reservation services | 93,657 | 88,724 | 13,597 | 318,215 | 332,899 | 51,019 | |||||||||||||
| Total revenues | 358,174 | 424,635 | 65,078 | 1,151,637 | 1,294,988 | 198,466 | |||||||||||||
| Cost of revenues | (58,511 | ) | (63,620 | ) | (9,750 | ) | (198,630 | ) | (212,206 | ) | (32,522 | ) | |||||||
| Gross profit | 299,663 | 361,015 | 55,328 | 953,007 | 1,082,782 | 165,944 | |||||||||||||
| Operating expenses: | |||||||||||||||||||
| Sales and marketing expenses | (132,152 | ) | (210,378 | ) | (32,242 | ) | (470,033 | ) | (726,297 | ) | (111,310 | ) | |||||||
| General and administrative expenses | (36,039 | ) | (49,888 | ) | (7,646 | ) | (160,531 | ) | (183,987 | ) | (28,197 | ) | |||||||
| Research and development expenses | (54,709 | ) | (70,920 | ) | (10,869 | ) | (177,268 | ) | (229,192 | ) | (35,125 | ) | |||||||
| Total operating expenses | (222,900 | ) | (331,186 | ) | (50,757 | ) | (807,832 | ) | (1,139,476 | ) | (174,632 | ) | |||||||
| Income/(loss) from operations | 76,763 | 29,829 | 4,571 | 145,175 | (56,694 | ) | (8,688 | ) | |||||||||||
| Other income/(expenses): | |||||||||||||||||||
| Investment income | 4,144 | 3,130 | 480 | 8,698 | 13,599 | 2,084 | |||||||||||||
| Interest income | 13,517 | 6,753 | 1,035 | 45,045 | 39,669 | 6,080 | |||||||||||||
| Exchange gains/(losses) | 441 | (603 | ) | (92 | ) | (3,235 | ) | (1,118 | ) | (171 | ) | ||||||||
| Impairment of long-term investments | (4,000 | ) | - | - | (4,000 | ) | - | - | |||||||||||
| Share of income/(losses) of equity method investee | - | 198 | 30 | - | (4,279 | ) | (656 | ) | |||||||||||
| Others, net | 8,089 | 11,407 | 1,748 | 34,776 | 8,916 | 1,366 | |||||||||||||
| Income before tax | 98,954 | 50,714 | 7,772 | 226,459 | 93 | 15 | |||||||||||||
| Income tax (expenses)/benefit | (29,009 | ) | (12,997 | ) | (1,992 | ) | (49,735 | ) | 4,784 | 733 | |||||||||
| Net income | 69,945 | 37,717 | 5,780 | 176,724 | 4,877 | 748 | |||||||||||||
| Net loss attributable to noncontrolling interests | - | (930 | ) | (143 | ) | - | (930 | ) | (143 | ) | |||||||||
| Net income attributable to So-Young International Inc. | 69,945 | 38,647 | 5,923 | 176,724 | 5,807 | 891 | |||||||||||||
| Accretions of convertible redeemable preferred shares to redemption value | - | - | - | (50,219 | ) | - | - | ||||||||||||
| Net income attributable to ordinary shareholders of the Company | 69,945 | 38,647 | 5,923 | 126,505 | 5,807 | 891 | |||||||||||||
SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Continued)
(Amounts in thousands, except for share and per share data)
| For the Three Months Ended | For the Fiscal Year Ended | ||||||||||||||||||
| December 31, 2019 | December 31, 2020 | December 31, 2020 | December 31, 2019 | December 31, 2020 | December 31, 2020 | ||||||||||||||
| RMB | RMB | US$ | RMB | RMB | US$ | ||||||||||||||
| Net income per ordinary share | |||||||||||||||||||
| Net earnings per ordinary share attributable to ordinary shareholder - basic | 0.89 | 0.47 | 0.07 | 2.13 | 0.07 | 0.01 | |||||||||||||
| Net earnings per ordinary share attributable to ordinary shareholder - diluted | 0.84 | 0.46 | 0.07 | 2.00 | 0.07 | 0.01 | |||||||||||||
| Net earnings per ADS attributable to ordinary shareholders - basic (13 ADS represents 10 Class A ordinary shares) | 0.68 | 0.36 | 0.06 | 1.64 | 0.05 | 0.01 | |||||||||||||
| Net earnings per ADS attributable to ordinary shareholders - diluted (13 ADS represents 10 Class A ordinary shares) | 0.65 | 0.35 | 0.05 | 1.54 | 0.05 | 0.01 | |||||||||||||
| Weighted average number of ordinary shares used in computing earnings per share, basic* | 79,030,547 | 81,904,047 | 81,904,047 | 59,357,935 | 81,534,991 | 81,534,991 | |||||||||||||
| Weighted average number of ordinary shares used in computing earnings per share, diluted* | 82,942,043 | 84,108,250 | 84,108,250 | 63,309,091 | 83,781,406 | 83,781,406 | |||||||||||||
| Share-based compensation expenses included in: | |||||||||||||||||||
| Cost of revenues | (4,052 | ) | (5,040 | ) | (772 | ) | (12,752 | ) | (18,327 | ) | (2,809 | ) | |||||||
| Sales and marketing expenses | (2,369 | ) | (2,183 | ) | (335 | ) | (8,479 | ) | (6,711 | ) | (1,029 | ) | |||||||
| General and administrative expenses | (5,074 | ) | (11,311 | ) | (1,733 | ) | (61,579 | ) | (46,001 | ) | (7,050 | ) | |||||||
| Research and development expenses | (4,934 | ) | (5,943 | ) | (911 | ) | (21,401 | ) | (21,131 | ) | (3,238 | ) | |||||||
| * Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted. | |||||||||||||||||||
SO-YOUNG INTERNATIONAL INC.
Reconciliation of GAAP and Non-GAAP Results
(Amounts in thousands, except for share and per share data)
| For the Three Months Ended | For the Fiscal Year Ended | |||||||||||||
| December 31, 2019 | December 31, 2020 | December 31, 2020 | December 31, 2019 | December 31, 2020 | December 31, 2020 | |||||||||
| RMB | RMB | US$ | RMB | RMB | US$ | |||||||||
| GAAP income/(loss) from operations | 76,763 | 29,829 | 4,571 | 145,175 | (56,694 | ) | (8,688 | ) | ||||||
| Add back: Shared-based compensation expenses | 16,429 | 24,477 | 3,751 | 104,211 | 92,170 | 14,126 | ||||||||
| Non-GAAP income from operations | 93,192 | 54,306 | 8,322 | 249,386 | 35,476 | 5,438 | ||||||||
| GAAP Net income | 69,945 | 37,717 | 5,780 | 176,724 | 4,877 | 748 | ||||||||
| Add back: Shared-based compensation expenses | 16,429 | 24,477 | 3,751 | 104,211 | 92,170 | 14,126 | ||||||||
| Non-GAAP net income | 86,374 | 62,194 | 9,531 | 280,935 | 97,047 | 14,874 | ||||||||
______________
1 This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB6.5250 to US
2 Non-GAAP net income is defined as net income excluding share-based compensation expenses. See “Reconciliation of GAAP and Non-GAAP Results” at the end of this press release.
FAQ
What were So-Young's total revenues for Q4 2020?
How much did So-Young's net income decrease in Q4 2020?
What is So-Young's revenue outlook for Q1 2021?
How many medical service providers are on So-Young's platform?
What was the gross margin for So-Young in Q4 2020?
